Skip to content

Effect of Nigella sativa oil on Prognosis of Acute Ischemic Stroke Patients

Evaluation the effect of Nigella Sativa oil on Acute Ischemic Stroke Outcome: A triple blind randomized placebo controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170112031893N4
Enrollment
80
Registered
2019-01-05
Start date
2019-02-20
Completion date
Unknown
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke. Cerebral infarction

Interventions

Intervention 1: Intervention group:The group used Nigella Sativa oil capsules amount 3 gram for 3 months, every day. Intervention 2: Control group: The group used placebo capsules amount 3 gram for 3

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: Acute ischemic stroke hospitalization in Shahid Beheshti hospital Not having a severe disability after stroke(NIHSS<20) Not to receive antioxidants (such as vitamin C and E) constantly Not affected by AIDS and neurodegenerative diseases (e.g. Alzheimer's, Parkinson's, amyotrophic lateral sclerosis

Exclusion criteria

Exclusion criteria: Request of patients to Exit from the study; Previous chronic disease interferes with the performance evaluation in patients such as: chronic infections, liver or kidney failure, cancers; Residual weakness of previous stroke Pregnancy or breastfeeding or any conditions that makes follow up impossible Sever loss of Consciousness Thrombolytic therapy Endarterectomy

Design outcomes

Primary

MeasureTime frame
Prognosis after stroke. Timepoint: At hospitalization(0), discharge(1), and after 3 months(2). Method of measurement: Functional status score based on NIHSS (National institutes of health stroke scale)(at least 50% reduction in NIHSS score in 3-month compared to the baseline score.

Secondary

MeasureTime frame
Prognosis after stroke. Timepoint: At hospitalization(0), discharge(1), and after 3 months(2). Method of measurement: Modified Rankin scale (MRS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Sharifi Pour

Ghoum University of Medical Sciences

driran1399@gmail.com+98 253886016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026